Colice, G.
AstraZeneca (United States)
2 papers on CoChat
Most cited papers
- Verified
Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
Popovic, B., Breed, J., Rees, D. G., Gardener, M. J., Vinall, L. M. K., Kemp, B., Spooner, J., Keen, J., Minter, R., Uddin, F., et al. (2017) · Journal of Molecular Biology
Monoclonal and Polyclonal Antibodies ResearchCytokine Signaling Pathways and Interactions
Cited by 198
- Verified
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Menzies-Gow, A., Ponnarambil, S., Downie, J., Bowen, K., Hellqvist, Å., & Colice, G. (2020) · Respiratory Research
Asthma and respiratory diseasesAllergic Rhinitis and Sensitization
Cited by 71
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free